Gland Pharma to expand in Genome Valley with ₹400 crore investment

Generic-injectable focused firm will add capabilities at its existing facility to manufacture biologicals, biosimilar, antibodies, recombinant insulin

from | The Hindu https://ift.tt/gmVbMLW